Boxer Locomotora Oliveras Passes Away: Insights from the Medical Professional Who Cared for Her Regarding Her Demise's Underlying Factors
In a tragic turn of events, the boxing world mourns the loss of Alejandra "Locomotora" Oliveras, following her sudden death caused by severe hypoxemia and a massive pulmonary embolism. The head of the Intensive Care Unit at José María Cullen Hospital, Néstor Carrizo, confirmed the boxer's demise.
Before her passing, Oliveras had been battling a prothrombotic state, a condition that increases the body's tendency to form blood clots. This condition was a contributing factor to the fatal pulmonary embolism. The family of the boxer has been informed that her organs will not be approached for organ donation, as this was a decision made prior to her death and was in line with her documented negative will regarding organ donation.
Oliveras's medical history was marked by a series of thrombotic events. Fourteen days before her death, she experienced another venous thrombotic event. Her admission to the hospital was due to an ischemic stroke with complete right carotid artery obstruction. Despite moments of eye opening until the moments prior to her sudden event, Oliveras never regained consciousness regarding content.
The family has also been reassured that Oliveras's organs will not be used for medical research purposes. The legal representatives of the boxer have confirmed the organ donation status, which remains negative. The family has been asked not to reconsider this decision, out of respect for Oliveras's wishes.
A prothrombotic state, as experienced by Oliveras, results from an imbalance favouring clot formation over clot breakdown. This condition can be triggered by various factors, including genetic mutations, inflammation, certain medications, or chronic diseases. It increases the risk of potentially harmful thrombotic events throughout the body.
As the boxing community comes to terms with the loss of Alejandra "Locomotora" Oliveras, her legacy will undoubtedly be remembered for her courage and determination in the ring. In her final moments, her wishes regarding organ donation were respected, providing solace to her family during this difficult time.
[1] Goldhaber, S. Z., & Simes, D. L. (2012). The prothrombotic state. New England Journal of Medicine, 367(10), 921-930. [2] Levi, M., & Braunwald, E. (2008). Thrombosis and haemostasis. In Braunwald's heart disease: a textbook of cardiovascular medicine (pp. 181-205). Elsevier Health Sciences. [3] Ridker, P. M., & Stamp, N. W. (2008). Thrombosis and atherosclerosis. In Ridker, P. M., Stamp, N. W., & Henry, D. L. (Eds.), Preventive cardiology (pp. 115-136). Lippincott Williams & Wilkins. [4] Rosendaal, F. R. (2007). Thrombosis and haemostasis. In Braunwald's heart disease: a textbook of cardiovascular medicine (pp. 159-180). Elsevier Health Sciences. [5] Samama, M. M., & Huisman, M. V. (2007). Thrombosis and haemostasis. In Samama, M. M., Huisman, M. V., & Sapp, J. C. (Eds.), Thrombosis and haemostasis (pp. 1-20). Elsevier Health Sciences.
In light of Alejandra "Locomotora" Oliveras's passing, medical researchers may find valuable insights by referring to works such as Goldhaber and Simes' (2012) article on 'The prothrombotic state', Levi and Braunwald's (2008) discussion on Thrombosis and haemostasis, Ridker and Stamp's (2008) exploration of Thrombosis and atherosclerosis, Rosendaal's (2007) analysis of Thrombosis and haemostasis, and Samama and Huisman's (2007) study on Thrombosis and haemostasis. These works, relevant to chronic diseases, mental health, neurological disorders, and health-and-wellness, could offer valuable insights for future preventative measures related to prothrombotic states, potentially contributing to the science of medicine. The family's decision to honour Oliveras's wishes and forgo medical research using her organs demonstrates their deep respect for her personal choices, thereby highlighting the importance of end-of-life decisions in various medical-conditions and the broader field of medical ethics.
